A panoramic, practice-based view of intravenous alteplase 3-4.5 h after stroke

被引：0
作者：
Kasner, Scott E. [1 ,2 ]
Levine, Steven R. [3 ,4 ,5 ]
机构：
[1] Univ Penn, Med Ctr, Stroke Ctr, Philadelphia, PA 19104 USA
[2] Univ Penn, Med Ctr, Dept Neurol, Philadelphia, PA 19104 USA
[3] SUNY Hlth Sci Ctr, Stroke Ctr, Brooklyn, NY 11203 USA
[4] SUNY Hlth Sci Ctr, Dept Neurol, Brooklyn, NY 11203 USA
[5] Sch Med, Brooklyn, NY 11203 USA
来源：
LANCET NEUROLOGY | 2010年 / 9卷 / 09期
关键词：
ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; THROMBOLYSIS; TIME;
D O I：
10.1016/S1474-4422(10)70169-1
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：843 / 845
页数：3
相关论文
共 30 条
  • [21] Cost-effectiveness of intravenous thrombolysis with alteplase within a 3-hour window after acute ischemic stroke
    Ehlers, Lars
    Andersen, Grethe
    Clausen, Lone Beltoft
    Bech, Merete
    Kjolby, Mette
    STROKE, 2007, 38 (01) : 85 - 89
  • [22] Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaernic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial
    Bluhmki, Erich
    Chamorro, Angel
    Davalos, Antoni
    Machnig, Thomas
    Sauce, Christophe
    Wahlgren, Nils
    Wardlaw, Joanna
    Hacke, Werner
    LANCET NEUROLOGY, 2009, 8 (12) : 1095 - 1102
  • [23] MRI based thrombolysis for FLAIR-negative stroke patients within 4.5-6 h after symptom onset
    Wei, Xiao-Er
    Zhou, Jia
    Li, Wen-Bin
    Zhao, Yu-Wu
    Li, Ming-Hua
    Li, Yue-Hua
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 372 : 421 - 427
  • [24] Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial
    Wardlaw, Joanna M.
    Sandercock, Peter
    Cohen, Geoff
    Farrall, Andrew
    Lindley, Richard I.
    von Kummer, Rudiger
    von Heijne, Anders
    Bradey, Nick
    Peeters, Andre
    Cala, Lesley
    Adami, Alessandro
    Morris, Zoe
    Potter, Gillian
    Murray, Gordon
    Whiteley, Will
    Perry, David
    Sakka, Eleni
    LANCET NEUROLOGY, 2015, 14 (05) : 485 - 496
  • [25] Intravenous recombinant tissue plasminogen activator administered after 3 h following onset of ischaemic stroke: a metaanalysis
    Maiser, Samuel J.
    Georgiadis, Alexandros L.
    Suri, M. Fareed K.
    Vazquez, Gabriela
    Lakshminarayan, Kamakshi
    Qureshi, Adnan I.
    INTERNATIONAL JOURNAL OF STROKE, 2011, 6 (01) : 25 - 32
  • [26] Early neurological deterioration in acute ischemic stroke patients after intravenous thrombolysis with alteplase predicts poor 3-month functional prognosis-data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China)
    Che, Fengli
    Wang, Anxin
    Ju, Yi
    Ding, Yarong
    Duan, Honglian
    Geng, Xiaokun
    Zhao, Xingquan
    Wang, Yongjun
    BMC NEUROLOGY, 2022, 22 (01)
  • [27] Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4.5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial
    Gusev, Eugene, I
    Martynov, Mikhail Yu
    Nikonov, Alexey A.
    Shamalov, Nikolay A.
    Semenov, Michail P.
    Gerasimets, Eugene A.
    Yarovaya, Elena B.
    Semenov, Andrey M.
    Archakov, Alexander, I
    Markin, Sergey S.
    LANCET NEUROLOGY, 2021, 20 (09) : 721 - 728
  • [28] Safety and efficacy of intravenous recombinant human prourokinase for acute ischaemic stroke within 4<middle dot>5 h after stroke onset (PROST-2): a phase 3, open-label non-inferiority, randomised controlled trial
    Li, Shuya
    Gu, Hong-Qiu
    Feng, Baoyu
    Li, Hao
    Wang, Xuechun
    Dong, Qiang
    Fan, Dongsheng
    Xu, Yun
    Zhu, Suiqiang
    Dai, Hongguo
    Wei, Yan
    Wang, Ziran
    Lu, Guozhi
    Ma, Yutong
    Li, Zixiao
    Wang, Yilong
    Meng, Xia
    Zhao, Xingquan
    Liu, Liping
    Wang, Yongjun
    LANCET NEUROLOGY, 2025, 24 (01) : 33 - 41
  • [29] Combined Intravenous and Intraarterial Revascularization Therapy Using MRI Perfusion/Diffusion Mismatch Selection for Acute Ischemic Stroke at 3–6 h After Symptom Onset
    Moon-Ku Han
    Sung Hyun Kim
    Sang-Bae Ko
    Nam-Jong Paik
    O-Ki Kwon
    Yong-Seok Lee
    Chang-Wan Oh
    Jae Hyoung Kim
    Seong-Ho Park
    Hee-Joon Bae
    Neurocritical Care, 2008, 8 : 353 - 359
  • [30] Combined intravenous and intraarterial revascularization therapy using MRI Perfusion/Diffusion mismatch selection for acute ischemic stroke at 3-6 h after symptom onset
    Han, Moon-Ku
    Kim, Sung Hyun
    Ko, Sang-Bae
    Paik, Nam-Jong
    Kwon, O-Ki
    Lee, Yong-Seok
    Oh, Chang-Wan
    Kim, Jae Hyoung
    Park, Seong-Ho
    Bae, Hee-Joon
    NEUROCRITICAL CARE, 2008, 8 (03) : 353 - 359
123